Lea Hachmeister advises companies and investors in the healthcare and life sciences market, with a focus on pharmaceutical and medical device companies. She specializes on transactions and strategic cooperations in the health and life sciences sector, regulatory issues, such as market entry and reimbursement channels for drugs and medical devices, as well as industry-specific data protection and compliance issues.
After her first state examination, she wrote a doctoral thesis on the topic of “Clinical trials with adults who are incapable of giving consent – legal framework of a group-benefit research”. Lea completed the additional qualification in pharmaceutical law at the Philips University in Marburg and worked as a research assistant at the chair of Prof. Dr. Wolfgang Voit during her doctoral thesis.
Advising pharmaceutical companies, wholesalers, pharmacies and medical devices companies on issues of pricing, market access and reimbursement by public and private payers, and public procurement
Advising pharmaceutical and medical device manufacturers as well as health insurers in the area of digital health
Advised a global internet company on telemedical business models in times of the COVID-19 crisis
Advising pharmaceutical companies and medical device manufacturers on the design and conduct of clinical trials
Advising German and international pharmaceutical companies and medical devices manufacturers on the regulation of advertising and promotion of medicinal products and medical devices, as well as on compliance with national and European codes of conduct
Support Association of the Research Centre for Pharmaceutical Law
German Legal Society for Animal Protection Right
Philipps-University Marburg, Dr. jur. (PhD), 2021
Higher Regional Court of Frankfurt, Second State Exam, 2021
Additional Qualification in Pharmaceutical Law with Distinction, 2016
Philipps-University Marburg, First State Exam, 2016
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.